Early diagnosis of tuberculous peritonitis in peritoneal dialysis patients using the T-SPOT test.

Peritoneal dialysis T-SPOT test Tuberculous peritonitis

Journal

CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244

Informations de publication

Date de publication:
21 Apr 2024
Historique:
received: 05 10 2023
accepted: 12 04 2024
medline: 21 4 2024
pubmed: 21 4 2024
entrez: 20 4 2024
Statut: aheadofprint

Résumé

A 49-year-old man was admitted with peritonitis nine months after starting continuous ambulatory peritoneal dialysis (CAPD) for kidney failure. Ceftazidime and cefazolin were started. Peritoneal dialysate culture was negative for bacteria, but antibiotic treatment was continued because peritonitis improved. Twenty days later, the patient was discharged with no signs of peritonitis. However, 40-day culture of the original peritoneal dialysate detected Mycobacterium tuberculosis, and peritonitis recurred, leading to readmission. A T-SPOT test was performed and was positive in 4 days. Anti-tuberculosis therapy was started, which cured the peritonitis. The T-SPOT test may enable early diagnosis of tuberculosis.

Identifiants

pubmed: 38643328
doi: 10.1007/s13730-024-00882-2
pii: 10.1007/s13730-024-00882-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Japanese Society of Nephrology.

Références

Li PK-T, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Peritoneal Dial Int. 2022;42(2):110–153.
Chow KM, Chow VC, Szeto CC. Indication for peritoneal biopsy in tuberculous peritonitis. Am J Surg. 2003;185(6):567–73.
doi: 10.1016/S0002-9610(03)00079-5 pubmed: 12781888
Ram R, Swarnalatha G, Akpolat T, Dakshinamurty KV. Mycobacterium tuberculous peritonitis in CAPD patients: a report of 11 patients and review of literature. Int Urol Nephrol. 2013;45(4):1129–35.
doi: 10.1007/s11255-012-0311-0 pubmed: 23143752
Sieloff EM, Ladzinski AT, Alcantara Lima N, Vos D, Boamah H, Melgar TA. Hospitalizations for tuberculous peritonitis in the United States: Results from the national inpatient sample database from 2002 to 2014. Int J Mycobacteriol. 2020;9(2):167–72.
doi: 10.4103/ijmy.ijmy_68_20 pubmed: 32474538
Hung YM, Chan HH, Chung HM. Tuberculous peritonitis in different dialysis patients in Southern Taiwan. Am J Trop Med Hyg. 2004;70(5):532–5.
doi: 10.4269/ajtmh.2004.70.532 pubmed: 15155986
Wang HK, Hsueh PR, Hung CC, Chang SC, Luh KT, Hsieh WC. Tuberculous peritonitis: analysis of 35 cases. J Microbiol Immunol Infect. 1998;31(2):113–8.
pubmed: 10596989
Marshall JB. Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol. 1993;88(7):989–99.
pubmed: 8317433
Su H, Yan G, Li Z, Fu L, Li L. Expression of adenosine deaminase and NLRP3 inflammasome in tuberculous peritonitis and their relationship with clinical efficacy. Dis Markers. 2022;2022:3664931.
doi: 10.1155/2022/3664931 pubmed: 36157218 pmcid: 9499801
Uzunkoy A, Harma M, Harma M. Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature. World J Gastroenterol. 2004;10(24):3647–9.
doi: 10.3748/wjg.v10.i24.3647 pubmed: 15534923 pmcid: 4612009
Yang TY, Tian YC, Yen TH, Chang MY, Lin CY, Liu S H. Tuberculous peritonitis in patients on peritoneal dialysis: a 35-year experience from a large medical center in Northern Taiwan. Renal Failure. 45(1): 2153064.
Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis. 2005;24(8):529–36.
doi: 10.1007/s10096-005-1377-8 pubmed: 16133410
Koff A, Azar MM. Diagnosing peritoneal tuberculosis. BMJ Case Rep. 2020;13(2): e233131.
doi: 10.1136/bcr-2019-233131 pubmed: 32033999 pmcid: 7035809
Luo Y, Xue Y, Mao L, Lin Q, Tang G, Song H, Wang F, Sun Z. Diagnostic value of T-SPOT.TB assay for tuberculous peritonitis: a meta-analysis. Front Med (Lausanne). 2020;7:585180
Fan Q, Huang X, Zhang J, Sun Y, Xiong Z, Xiong Z. Value of gamma interferon enzyme-linked immunospot assay in the diagnosis of peritoneal dialysis-associated tuberculous peritonitis. Int Urol Nephrol. 2022;54(4):843–9.
doi: 10.1007/s11255-021-02960-1 pubmed: 34263436
Edwards S, Glynn P, David MD, Kamesh L. Diagnosing tuberculous peritonitis early in patients on peritoneal dialysis: use of Xpert MTB/RIF assay. Perit Dial Int. 2016;36(4):461–3.
doi: 10.3747/pdi.2015.00233 pubmed: 27385809 pmcid: 4934444
Fung WW, Chow KM, Ng JK, Chan GC, Li PK, Szeto CC. The clinical utility of the neutrophil-to-lymphocyte ratio as a discriminatory test among bacterial, mycobacterium tuberculosis, and nontuberculous mycobacterium peritoneal dialysis-related peritonitis. Kidney360. 2022;3(6):1031–1038.

Auteurs

Naoto Okubo (N)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan. onaoto28@gmail.com.

Tatsuya Suwabe (T)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Masayuki Yamanouchi (M)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Daisuke Ikuma (D)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Hiroki Mizuno (H)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Yuki Oba (Y)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Katsuyuki Miki (K)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Takayoshi Yokoyama (T)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Yasuo Ishii (Y)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Naoki Sawa (N)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Yuki Nakamura (Y)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.

Hisashi Takaya (H)

Department of Respiratory Medicine, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.

Yoshifumi Ubara (Y)

Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan. ubara@toranomon.gr.jp.

Classifications MeSH